Assistant Professor, Urology, University of Wisconsin Medical School
Urology
Dr. Edwin J. Abel, MD
|
|
Give Review
Edwin Abel works in the field of Urology. He studied medicine at University of Texas Medical School. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Edwin Abel is also published. He has 28 publications published. The lastest publication: "The evolving role of renal mass biopsy.' Edwin Abel accepts Medicare payments and is listed with Medicare.gov.
Publications
- Extreme Obesity Does Not Predict Poor Cancer Outcomes Following Surgery for Renal Cell Cancer.
- Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer.
- Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis.
- Percutaneous biopsy for risk stratification of Renal masses.
- Percutaneous Microwave Ablation of Renal Angiomyolipomas.
- Multi-Quadrant Biopsy Technique Improves Diagnostic Ability in Large Heterogeneous Renal Masses.
- Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of Renal cell carcinoma with suprahepatic ...
- Addressing the need for repeat Prostate biopsy: new technology and approaches.
- Highest risk of symptomatic venous thromboembolic events after radical cystectomy occurs in patients with obesity or nonurothelial Cancers.
- Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced Renal cell carcinoma (RCC): in...
- Patient and Tumor Characteristics can Predict Non-Diagnostic Renal Mass Biopsy Findings.
- Oncologic outcomes following surgical resection of Renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter...
- Perioperative Blood Transfusion and Radical Cystectomy: Does Timing of Transfusion Affect Bladder Cancer Mortality?
- NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the Bladder.
- High-Powered Microwave Ablation of T1a Renal Cell Carcinoma: Safety and Initial Clinical Evaluation.
- Analysis and validation of tissue biomarkers for Renal cell carcinoma using automated high-throughput evaluation of protein expression.
- Perioperative Outcomes Following Surgical Resection of Renal Cell Carcinoma with Inferior Vena Cava Thrombus Extending Above the Hepatic Veins: A Contemporary Multicen...
- Positive vascular wall margins have minimal impact on Cancer outcomes in non-metastatic RCC patients with tumor thrombus.
- Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate Cancer.
- Preoperative pulmonary embolism does not predict poor postsurgical outcomes in RCC patients with venous thrombus.
- Ablation of Small Renal Masses: Practice Patterns at Academic Institutions in the United States.
- Development of Accurate Models for Individualized Prediction of Survival After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.
- Limitations of preoperative biopsy in patients with metastatic Renal cell carcinoma: comparison to surgical pathology in 405 cases.
- Laparoscopic marsupialization before inguinal repair of large abdominoscrotal hydroceles in infants: observation of natural history and description of technique.
- Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic Prostatectomy.
- Delayed ureterectomy after incomplete nephroureterectomy for upper Tract urothelial carcinoma: pathologic findings and outcomes.
- The evolving role of Renal mass biopsy.
Schools
University of Texas At Houston Medical School At Houston
Procedures Preformed
- AdRenalectomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Kidney and Ureter Removal
- Kidney Stone Removal (Percutaneous Nephrostolithotomy, PCNL)
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Choice Plus POS II
- American Enterprise Group
- American Republic
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Preferred Plus POS
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- HealthPartners
- Humana
- Medicare MCR
- Mutual of Omaha
- Thrivent Financial
- United Healthcare
- Universal American
- Wisconsin Physicians Service
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
University of Texas MD Anderson Cancer Center -
University of Utah -
University of Texas Medical School
Hospital
-
University of Wisconsin Hospital and Clinics -
William S. Middleton Memorial Veterans Hospital
Drug Facts
| NPI NUMBER | 1083800510 | |
| NPPES Provider LastName | ABEL | |
| NPPES Provider FirstName | EDWIN | |
| NPPES Provider ZIPCode | 537920001 | |
| NPPES Provider State | WI | |
| Specialty Description | Urology | |
| Total Claim Count | 86.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 19.0 | |
| Percent Opioid Claims | 22.09 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083800510 |
| Last Name Of The Provider | ABEL |
| First Name Of The Provider | EDWIN |
| View All |
Similar Doctors
|
|
Dr. Diana E. Lardy, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew W. Christian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracy M. Downs, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gary M. Licklider, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Blute, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sara L. Best, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kathryn A. Lipscomb, MD |
|
|
Dr. Amy H. Lim, MD |